Legal eagles Slater & Gordon keep flying higher: Should you buy?

Let the lawyers do the hard work as you watch the World Cup!

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Lawyers have a hard won reputation for a love of making money, so why not get some to do the hard yards for you? Slater & Gordon Limited (ASX: SGH) is a growth business run by some entrepreneurial lawyers with big plans to grow in the lucrative United Kingdom legal market. In fact these legal eagles are forecasting around $155 million in post-acquisitions revenue from UK operations in 2014, out of a total revenue forecast of $395 million. A large proportion of Australian revenues are a result of personal injury cases, although the business is now diversifying its fee-earning potential into more general legal services.

With an EBIT margin of around 20% for the first-half of FY 2014, net profit came in at $23 million on $178.3 million of revenue. The group's revenue diversification strategy is on track and the fragmented UK legal market looks a match made in heaven for a business on an acquisitive trail. It has been able to buy several smaller UK firms on around 3.5 to 4.5 times earnings, with the effects expected to be earnings per share accretive this financial year. Net debt to equity remains at a manageable 24.2% and while consolidation is now important, Slater and Gordon's shopping spree may not be over yet. An appreciating UK pound over the past financial year should also provide full-year profits a strong tailwind.

The basic business model is to build a leading consumer services legal business based on brand strength and a solid reputation, which goes a long way in Slater and Gordon's legal fields. Currently it is estimated Slater and Gordon only has around a 5% interest in the UK personal injuries legal market, so if successful the potential is there for much bigger growth.

Selling for $5.15 Slater and Gordon is trading around 17.5 times projected earnings in FY 2014 and around 14 times projected earnings in FY 2015. For a growth business with potential to outperform that looks a reasonable valuation.

Other lawyers on the acquisitive trail recently include rival Shine Corporate Ltd (ASX: SHJ), which is a business that would like to emulate the success of Slater & Gordon. While IMF Bentham Ltd (ASX: IMF) is a litigation funder looking to expand in the high-stakes North American market. There's one more company I like offering..

Motley Fool contributor Tom Richardson owns shares in Slater and Gordon. You can find him on Twitter @tommyr345

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »